Robert M. Hermann

Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5‐fluorouracil and mitomycin‐C

H. Christiansen, C. Hess, R. Hermann, 2004, Head & neck.

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy

F. Bruns, Jan-Niklas Becker, Mathias Sonnhoff, 2023, PloS one.

Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer

H. Christiansen, H. Vorwerk, C. Hess, 2009, Strahlentherapie und Onkologie.

Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma.

H. Christiansen, C. Hess, R. Hermann, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?

H. Christiansen, R. Hermann, F. Haller, 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE.

M. Kris, R. Herbst, V. Miller, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.